Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...
According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...
Before receiving treatment for acute myeloid leukemia, I made it a point to take advantage of all the resources that were ...
The researchers suggest certain refinements to the 2022 European LeukemiaNet classification model for patients aged 60 years ...
ICT01 showed tolerable safety and promising clinical activity as a monotherapy and is now being investigated in combination ...
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...